Real-time Estimate
Cboe BZX
02:01:23 2025-02-13 pm EST
5-day change
1st Jan Change
10.84 USD
+1.50%
-5.43%
+17.65%
Top Midday Gainers
October 31, 2024 at 02:00 pm EDT
Alphatec Holdings, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 05:15 PM
Jan. 15
Jefferies Raises Alphatec Holdings Price Target to $19 From $16, Maintains Buy Rating
Jan. 14
MT
Alphatec Holdings, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2024 and Full Year 2025
Jan. 13
CI
Alphatec Holdings Insider Sold Shares Worth $600,954, According to a Recent SEC Filing
Dec. 13
MT
Alphatec Files Secondary Stock Shelf to Cover Exercise of Warrants
Nov. 15
MT
Top Midday Gainers
24-10-31
MT
Wall Street Set to Open Lower Thursday; Inflation Data Meets Expectations, Initial Jobless Claims Decline
24-10-31
MT
BioPharma Credit PLC Announces New Investment in Alphatec Holdings, Inc.'s Senior Secured Loan
24-10-31
CI
Earnings Flash (ATEC) ALPHATEC HOLDINGS Reports Q3 Revenue $151M
24-10-30
MT
Alphatec Holdings, Inc., Q3 2024 Earnings Call, Oct 30, 2024
24-10-30
Alphatec Holdings, Inc. Revises Earnings Guidance for the Year Ended December 31, 2024
24-10-30
CI
Alphatec Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
24-10-30
CI
Needham Adjusts Price Target on Alphatec to $13 From $23, Maintains Buy Rating
24-08-22
MT
Alphatec Holdings Insider Bought Shares Worth $255,450, According to a Recent SEC Filing
24-08-05
MT
Alphatec Holdings Insider Bought Shares Worth $262,400, According to a Recent SEC Filing
24-08-05
MT
Alphatec Holdings Insider Bought Shares Worth $255,450, According to a Recent SEC Filing
24-08-05
MT
Alphatec Holdings Insider Bought Shares Worth $262,400, According to a Recent SEC Filing
24-08-05
MT
Morgan Stanley Downgrades Alphatec Holdings to Equalweight From Overweight, Halves Price Target to $8 From $16
24-08-02
MT
Top Premarket Decliners
24-08-01
MT
Alphatec Holdings, Inc., Q2 2024 Earnings Call, Jul 31, 2024
24-07-31
Alphatec Holdings, Inc. Appoints Keith Valentine to Serve as Director of the Company and as Member of the Company's Nominating and Corporate Governance Committee
24-07-31
CI
Earnings Flash (ATEC) ALPHATEC HOLDINGS Reports Q2 Revenue $146M, vs. Street Est of $144.5M
24-07-31
MT
Earnings Flash (ATEC) ALPHATEC HOLDINGS Reports Q2 Revenue $146M, vs. Street Est of $144.5M
24-07-31
MT
Alphatec Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024
24-07-31
CI
Alphatec Holdings, Inc. Launches Eos Insighttm, an End-To-End Spine Surgery Platform Powered by Eos Imaging and Ai
24-07-24
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
ATEC: Dynamic Chart
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patientsâ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
More about the company
Last Close Price
10.68 USD
Average target price
17.46 USD
Spread / Average Target
+63.47%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1